TIM
Thompson Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Hold |
9,755
| – | – | 0.17% | 99 |
|
|
2025
Q1 | $1.08M | Buy |
9,755
+925
| +10% | +$102K | 0.16% | 99 |
|
|
2024
Q4 | $1.21M | Sell |
8,830
-920
| -9% | -$126K | 0.17% | 101 |
|
|
2024
Q3 | $1.12M | Buy |
9,750
+1,850
| +23% | +$213K | 0.16% | 98 |
|
|
2024
Q2 | $1.09M | Buy |
7,900
+275
| +4% | +$37.9K | 0.17% | 96 |
|
|
2024
Q1 | $1.05M | Sell |
7,625
-75
| -1% | -$10.3K | 0.16% | 97 |
|
|
2023
Q4 | $1.01M | Sell |
7,700
-575
| -7% | -$75.8K | 0.16% | 99 |
|
|
2023
Q3 | $931K | Sell |
8,275
-330
| -4% | -$37.1K | 0.17% | 99 |
|
|
2023
Q2 | $811K | Buy |
8,605
+375
| +5% | +$35.4K | 0.13% | 106 |
|
|
2023
Q1 | $833K | Buy |
8,230
+1,725
| +27% | +$175K | 0.14% | 104 |
|
|
2022
Q4 | $777K | Hold |
6,505
| – | – | 0.14% | 109 |
|
|
2022
Q3 | $691K | Sell |
6,505
-1,300
| -17% | -$138K | 0.13% | 111 |
|
|
2022
Q2 | $761K | Hold |
7,805
| – | – | 0.13% | 110 |
|
|
2022
Q1 | $732K | Buy |
7,805
+500
| +7% | +$46.9K | 0.11% | 119 |
|
|
2021
Q4 | $622K | Buy |
7,305
+375
| +5% | +$31.9K | 0.09% | 132 |
|
|
2021
Q3 | $665K | Hold |
6,930
| – | – | 0.1% | 131 |
|
|
2021
Q2 | $674K | Buy |
6,930
+2,500
| +56% | +$243K | 0.1% | 135 |
|
|
2021
Q1 | $431K | Hold |
4,430
| – | – | 0.07% | 153 |
|
|
2020
Q4 | $425K | Buy |
4,430
+700
| +19% | +$67.2K | 0.07% | 143 |
|
|
2020
Q3 | $359K | Buy |
3,730
+330
| +10% | +$31.8K | 0.07% | 142 |
|
|
2020
Q2 | $415K | Buy |
+3,400
| New | +$415K | 0.08% | 136 |
|